Aldeyra Therapeutics (137.MU) Q3 2026 Earnings

31JulConfirmed
Q1 2026
Next
Next
-0.12
-0.1
-0.08
-0.06

Details

Expected EPS
-0.09644625
Actual EPS
N/A
Surprise EPS
0.1
Surprise Percent
+100%

Description

Aldeyra Therapeutics (137.MU) will report earnings of for Q3 2026 on July 31, 2026.

0 Comments

Share your thoughts